David O'Dwyer, MD, PhD
Associate Professor of Internal Medicine
Associate Professor of Microbiology and Immunology
[email protected]

Available to mentor
David O'Dwyer, MD, PhD
Associate Professor
  • About
  • Qualifications
  • Recent Publications
    • About

    Dr. O’Dwyer is an Associate Professor in the Division of Pulmonary and Critical Care Medicine at the University of Michigan. He graduated from University College Cork Medical School, National University of Ireland in 2004. Dr. O’Dwyer completed his internal medicine residency training through the Royal College of Surgeons of Ireland and was awarded membership of the Royal College of Physicians (RCPI) in 2007. He completed a clinical fellowship in internal medicine and pulmonary medicine at St. Vincents University Hospital and the Royal College of Physicians in 2014. He completed research training in pulmonary medicine graduating with a PhD in pulmonary fibrosis from University College Dublin, National University of Ireland in 2014. He completed clinical fellowship training in pulmonary and critical care medicine at the University of Michigan in 2017.

    Qualifications
    • PhD
      University College Dublin, NUI, National University of Ireland Stillorgan Road, 2014
    • MB BCH BAO
      University College Cork School of Medicine, National University of Ireland (NUI), National University of Ireland Room 2.59, Brookfield Health Sciences Complex, 2004
    Recent Publications See All Publications
    • Presentation
      Progressive oral dysbiosis associates with clinical outcomes in IPF
      O'Dwyer D. 2024 Oct 15;
    • Presentation
      Oral microbiota and IPF progression
      O'Dwyer D. 2024 Sep 6;
    • Journal Article
      Reply to Fujimoto et al.: Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis.
      O'Dwyer DN, Noth I, Oldham JM. Am J Respir Crit Care Med, 2024 Aug 15; 210 (4): 528 - 530. DOI:10.1164/rccm.202312-2262LE
      PMID: 38271703
    • Journal Article
      Reply to Ward et al.: Integrating Aerodigestive Investigations in Progressive Pulmonary Fibrosis.
      O'Dwyer DN, Kim JS, Noth I. Am J Respir Crit Care Med, 2024 Aug 15; 210 (4): 530 - 531. DOI:10.1164/rccm.202406-1123LE
      PMID: 38941619
    • Preprint
      Lung Microbiome Intervention Attenuates Herpesvirus-Induced Post-HCT Pulmonary Fibrosis Through PD-L1 Upregulation on Dendritic Cells
      Perkins J, Ravi K, Guo C, Oh G, Rodriguez B, Gurczynski S, Weinberg J, Huffnagle G, O’Dwyer D, Moore B, Zhou X. 2024 bioRxiv, DOI:10.1101/2024.07.06.602351
    • Journal Article
      The Oral-Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease.
      Bongers KS, Massett A, O'Dwyer DN. Semin Respir Crit Care Med, 2024 Jun; 45 (3): 449 - 458. DOI:10.1055/s-0044-1785673
      PMID: 38626906
    • Journal Article
      Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
      O'Dwyer DN, Kim JS, Ma S-F, Ranjan P, Das P, Lipinski JH, Metcalf JD, Falkowski NR, Yow E, Anstrom K, Dickson RP, Huang Y, Gilbert JA, Martinez FJ, Noth I. Am J Respir Crit Care Med, 2024 May 1; 209 (9): 1101 - 1110. DOI:10.1164/rccm.202308-1357OC
      PMID: 38051927
    • Journal Article
      The Lung Microbiome
      O'Dwyer D. 2024 Apr 15; DOI:10.4049/jimmunol.2300716